CBIZ INC (CBZ)

US1248051021 - Common Stock

80.79  +1.36 (+1.71%)

After market: 80.79 0 (0%)

Fundamental Rating

5

Taking everything into account, CBZ scores 5 out of 10 in our fundamental rating. CBZ was compared to 80 industry peers in the Professional Services industry. Both the profitability and the financial health of CBZ get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CBZ is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
CBZ had a positive operating cash flow in the past year.
CBZ had positive earnings in each of the past 5 years.
CBZ had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 5.58%, CBZ is doing good in the industry, outperforming 62.03% of the companies in the same industry.
CBZ has a better Return On Equity (12.83%) than 60.76% of its industry peers.
The Return On Invested Capital of CBZ (7.15%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBZ is significantly below the industry average of 18.09%.
Industry RankSector Rank
ROA 5.58%
ROE 12.83%
ROIC 7.15%
ROA(3y)5.29%
ROA(5y)5.22%
ROE(3y)13.37%
ROE(5y)12.4%
ROIC(3y)7.99%
ROIC(5y)7.14%

1.3 Margins

CBZ's Profit Margin of 7.08% is fine compared to the rest of the industry. CBZ outperforms 74.68% of its industry peers.
CBZ's Profit Margin has improved in the last couple of years.
CBZ has a Operating Margin of 9.71%. This is in the better half of the industry: CBZ outperforms 72.15% of its industry peers.
In the last couple of years the Operating Margin of CBZ has remained more or less at the same level.
Looking at the Gross Margin, with a value of 13.83%, CBZ is doing worse than 91.14% of the companies in the same industry.
In the last couple of years the Gross Margin of CBZ has remained more or less at the same level.
Industry RankSector Rank
OM 9.71%
PM (TTM) 7.08%
GM 13.83%
OM growth 3Y3.37%
OM growth 5Y1.08%
PM growth 3Y-2.18%
PM growth 5Y2.62%
GM growth 3Y-0.52%
GM growth 5Y-0.19%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBZ is destroying value.
Compared to 1 year ago, CBZ has less shares outstanding
Compared to 5 years ago, CBZ has less shares outstanding
The debt/assets ratio for CBZ is higher compared to a year ago.

2.2 Solvency

CBZ has an Altman-Z score of 3.83. This indicates that CBZ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.83, CBZ is in the better half of the industry, outperforming 69.62% of the companies in the same industry.
The Debt to FCF ratio of CBZ is 2.24, which is a good value as it means it would take CBZ, 2.24 years of fcf income to pay off all of its debts.
CBZ has a Debt to FCF ratio of 2.24. This is in the better half of the industry: CBZ outperforms 72.15% of its industry peers.
CBZ has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
CBZ has a Debt to Equity ratio of 0.36. This is comparable to the rest of the industry: CBZ outperforms 51.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.24
Altman-Z 3.83
ROIC/WACC0.78
WACC9.16%

2.3 Liquidity

A Current Ratio of 1.49 indicates that CBZ should not have too much problems paying its short term obligations.
With a Current ratio value of 1.49, CBZ perfoms like the industry average, outperforming 53.16% of the companies in the same industry.
A Quick Ratio of 1.49 indicates that CBZ should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.49, CBZ perfoms like the industry average, outperforming 53.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.73% over the past year.
Measured over the past years, CBZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.90% on average per year.
Looking at the last year, CBZ shows a small growth in Revenue. The Revenue has grown by 7.83% in the last year.
The Revenue has been growing by 11.53% on average over the past years. This is quite good.
EPS 1Y (TTM)3.73%
EPS 3Y19.07%
EPS 5Y16.9%
EPS Q2Q%25.37%
Revenue 1Y (TTM)7.83%
Revenue growth 3Y18.19%
Revenue growth 5Y11.53%
Sales Q2Q%6.9%

3.2 Future

Based on estimates for the next years, CBZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.11% on average per year.
CBZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.15% yearly.
EPS Next Y13.09%
EPS Next 2Y14.23%
EPS Next 3Y13.11%
EPS Next 5YN/A
Revenue Next Year8.5%
Revenue Next 2Y6.94%
Revenue Next 3Y17.15%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.32, CBZ can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CBZ is valued a bit more expensive than the industry average as 63.29% of the companies are valued more cheaply.
CBZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.29.
Based on the Price/Forward Earnings ratio of 26.01, the valuation of CBZ can be described as expensive.
CBZ's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.01. CBZ is around the same levels.
Industry RankSector Rank
PE 32.32
Fwd PE 26.01

4.2 Price Multiples

CBZ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CBZ is more expensive than 64.56% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBZ is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.9
EV/EBITDA 21.83

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CBZ may justify a higher PE ratio.
CBZ's earnings are expected to grow with 13.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.47
PEG (5Y)1.91
EPS Next 2Y14.23%
EPS Next 3Y13.11%

0

5. Dividend

5.1 Amount

CBZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (11/22/2024, 8:04:00 PM)

After market: 80.79 0 (0%)

80.79

+1.36 (+1.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.05B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 32.32
Fwd PE 26.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.47
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 5.58%
ROE 12.83%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.71%
PM (TTM) 7.08%
GM 13.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.73%
EPS 3Y19.07%
EPS 5Y
EPS Q2Q%
EPS Next Y13.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.83%
Revenue growth 3Y18.19%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y